Hypertrophic cardiomyopathy in children

Arman Arghami; Joseph A. Dearani; Sameh M. Said; Patrick W. O'Leary; Hartzell V. Schaff

doi:10.21037/acs.2017.07.04

Hypertrophic cardiomyopathy in children

Arman Arghami, Joseph A. Dearani, Sameh M. Said, Patrick W. O'Leary, Hartzell V. Schaff

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Hypertrophic cardiomyopathy (HCM) occurs in 1 of 500 adults and is considered to be one of the most common causes of death in young people under 35 years of age. Children with HCM are usually asymptomatic and the overall annual mortality beyond the first year of life is 1%. Septal myectomy is safe and effective in children with obstructive HCM and published data shows improved late survival compared to untreated HCM. Patient selection and surgical expertise remain critical components to ensuring successful outcomes of septal myectomy, particularly when considering prophylactic myectomy in a seemingly asymptomatic patient.

Original language	English (US)
Pages (from-to)	376-385
Number of pages	10
Journal	Annals of Cardiothoracic Surgery
Volume	6
Issue number	4
DOIs	https://doi.org/10.21037/acs.2017.07.04
State	Published - Jul 1 2017

Keywords

Hypertrophic cardiomyopathy (HCM)
Septal myectomy

ASJC Scopus subject areas

Surgery
Cardiology and Cardiovascular Medicine

Access to Document

10.21037/acs.2017.07.04

Cite this

@article{f8b205dce8914046948464644cb82bcc,

title = "Hypertrophic cardiomyopathy in children",

abstract = "Hypertrophic cardiomyopathy (HCM) occurs in 1 of 500 adults and is considered to be one of the most common causes of death in young people under 35 years of age. Children with HCM are usually asymptomatic and the overall annual mortality beyond the first year of life is 1%. Septal myectomy is safe and effective in children with obstructive HCM and published data shows improved late survival compared to untreated HCM. Patient selection and surgical expertise remain critical components to ensuring successful outcomes of septal myectomy, particularly when considering prophylactic myectomy in a seemingly asymptomatic patient.",

keywords = "Hypertrophic cardiomyopathy (HCM), Septal myectomy",

author = "Arman Arghami and Dearani, {Joseph A.} and Said, {Sameh M.} and O'Leary, {Patrick W.} and Schaff, {Hartzell V.}",

note = "Publisher Copyright: {\textcopyright} Annals of Cardiothoracic Surgery.",

year = "2017",

month = jul,

day = "1",

doi = "10.21037/acs.2017.07.04",

language = "English (US)",

volume = "6",

pages = "376--385",

journal = "Annals of Cardiothoracic Surgery",

issn = "2225-319X",

publisher = "AME Publishing Company",

number = "4",

}

TY - JOUR

T1 - Hypertrophic cardiomyopathy in children

AU - Arghami, Arman

AU - Dearani, Joseph A.

AU - Said, Sameh M.

AU - O'Leary, Patrick W.

AU - Schaff, Hartzell V.

N1 - Publisher Copyright: © Annals of Cardiothoracic Surgery.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Hypertrophic cardiomyopathy (HCM) occurs in 1 of 500 adults and is considered to be one of the most common causes of death in young people under 35 years of age. Children with HCM are usually asymptomatic and the overall annual mortality beyond the first year of life is 1%. Septal myectomy is safe and effective in children with obstructive HCM and published data shows improved late survival compared to untreated HCM. Patient selection and surgical expertise remain critical components to ensuring successful outcomes of septal myectomy, particularly when considering prophylactic myectomy in a seemingly asymptomatic patient.

AB - Hypertrophic cardiomyopathy (HCM) occurs in 1 of 500 adults and is considered to be one of the most common causes of death in young people under 35 years of age. Children with HCM are usually asymptomatic and the overall annual mortality beyond the first year of life is 1%. Septal myectomy is safe and effective in children with obstructive HCM and published data shows improved late survival compared to untreated HCM. Patient selection and surgical expertise remain critical components to ensuring successful outcomes of septal myectomy, particularly when considering prophylactic myectomy in a seemingly asymptomatic patient.

KW - Hypertrophic cardiomyopathy (HCM)

KW - Septal myectomy

UR - http://www.scopus.com/inward/record.url?scp=85026544864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026544864&partnerID=8YFLogxK

U2 - 10.21037/acs.2017.07.04

DO - 10.21037/acs.2017.07.04

M3 - Article

AN - SCOPUS:85026544864

SN - 2225-319X

VL - 6

SP - 376

EP - 385

JO - Annals of Cardiothoracic Surgery

JF - Annals of Cardiothoracic Surgery

IS - 4

ER -

Hypertrophic cardiomyopathy in children

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this